BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38510473)

  • 1. Comprehensive genomic analysis of early and late-onset hepatocellular carcinoma.
    Yang J; Chen C; Wang S; Zhang Y; Pang J; Wang Y; Ou Q; Jiang H; Liu J
    Genes Dis; 2024 Jul; 11(4):101031. PubMed ID: 38510473
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk factors for early-onset and late-onset hepatocellular carcinoma in Asian immigrants with hepatitis B in the United States.
    Wan DW; Tzimas D; Smith JA; Kim S; Araujo J; David R; Lobach I; Sarpel U
    Am J Gastroenterol; 2011 Nov; 106(11):1994-2000. PubMed ID: 21912436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the genotype and integration patterns of hepatitis B virus in early- and late-onset hepatocellular carcinoma.
    Yan H; Yang Y; Zhang L; Tang G; Wang Y; Xue G; Zhou W; Sun S
    Hepatology; 2015 Jun; 61(6):1821-31. PubMed ID: 25627239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Mutator-Derived lncRNA Signatures of Genomic Instability for Promoting the Clinical Outcome in Hepatocellular Carcinoma.
    Tang X; Miao Y; Wang J; Cai T; Yang L; Mi D
    Comput Math Methods Med; 2021; 2021():1205029. PubMed ID: 34840594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification of early and late stage liver hepatocellular carcinoma patients from their genomics and epigenomics profiles.
    Kaur H; Bhalla S; Raghava GPS
    PLoS One; 2019; 14(9):e0221476. PubMed ID: 31490960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeat hepatectomy for patients with early and late recurrence of hepatocellular carcinoma: A multicenter propensity score matching analysis.
    Xing H; Sun LY; Yan WT; Quan B; Liang L; Li C; Zhou YH; Wang H; Zhong JH; Gu WM; Chen TH; Wang MD; Wu H; Pawlik TM; Lau WY; Wu MC; Shen F; Yang T
    Surgery; 2021 Apr; 169(4):911-920. PubMed ID: 31879090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of the risk factors for recurrence of early and late stage hepatocellular carcinoma after hepatic artery embolization combined with radiofrequency ablation therapy].
    Sun Y; Zhang HH; Zheng JS; Zhang YH
    Zhonghua Gan Zang Bing Za Zhi; 2021 Oct; 29(10):1001-1005. PubMed ID: 34814396
    [No Abstract]   [Full Text] [Related]  

  • 8. Genome-wide identification of blood DNA methylation patterns associated with early-onset hepatocellular carcinoma development in hepatitis B carriers.
    Kao WY; Yang SH; Liu WJ; Yeh MY; Lin CL; Liu CJ; Huang CJ; Lin SM; Lee SD; Chen PJ; Yu MW
    Mol Carcinog; 2017 Feb; 56(2):425-435. PubMed ID: 27254796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early and Late Recurrence of Hepatitis B Virus-Associated Hepatocellular Carcinoma.
    Wang MD; Li C; Liang L; Xing H; Sun LY; Quan B; Wu H; Xu XF; Wu MC; Pawlik TM; Lau WY; Shen F; Yang T
    Oncologist; 2020 Oct; 25(10):e1541-e1551. PubMed ID: 32472951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of four distinct regions of allelic imbalances on chromosome 1 by the combined comparative genomic hybridization and microsatellite analysis on hepatocellular carcinoma.
    Leung TH; Wong N; Lai PB; Chan A; To KF; Liew CT; Lau WY; Johnson PJ
    Mod Pathol; 2002 Nov; 15(11):1213-20. PubMed ID: 12429801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic predictors for recurrence patterns of hepatocellular carcinoma: model derivation and validation.
    Kim JH; Sohn BH; Lee HS; Kim SB; Yoo JE; Park YY; Jeong W; Lee SS; Park ES; Kaseb A; Kim BH; Kim WB; Yeon JE; Byun KS; Chu IS; Kim SS; Wang XW; Thorgeirsson SS; Luk JM; Kang KJ; Heo J; Park YN; Lee JS
    PLoS Med; 2014 Dec; 11(12):e1001770. PubMed ID: 25536056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left-sided early-onset vs late-onset colorectal carcinoma: histologic, clinical, and molecular differences.
    Pilozzi E; Maresca C; Duranti E; Giustiniani MC; Catalanotto C; Lucarelli M; Cogoni C; Ferri M; Ruco L; Zardo G
    Am J Clin Pathol; 2015 Mar; 143(3):374-84. PubMed ID: 25696795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CT diagnosis of early hepatocellular carcinoma: sensitivity, findings, and CT-pathologic correlation.
    Takayasu K; Furukawa H; Wakao F; Muramatsu Y; Abe H; Terauchi T; Winter TC; Sakamoto M; Hirohashi S
    AJR Am J Roentgenol; 1995 Apr; 164(4):885-90. PubMed ID: 7726041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late-onset benefit in progressive advanced hepatocellular carcinoma with continued sorafenib therapy: a case report.
    Okuwaki Y; Nakazawa T; Hidaka H; Shibuya A; Koizumi W
    J Med Case Rep; 2012 Jan; 6():38. PubMed ID: 22280970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of occult hepatitis B virus infection on the early-onset of hepatocellular carcinoma in patients with hepatitis C virus infection.
    Nakano M; Kawaguchi T; Nakamoto S; Kawaguchi A; Kanda T; Imazeki F; Kuromatsu R; Sumie S; Satani M; Yamada S; Torimura T; Kakuma T; Yokosuka O; Sata M
    Oncol Rep; 2013 Nov; 30(5):2049-55. PubMed ID: 23982634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex difference in recurrence and survival after liver resection for hepatocellular carcinoma: A multicenter study.
    Zhang H; Han J; Xing H; Li ZL; Schwartz ME; Zhou YH; Chen TH; Wang H; Gu WM; Lau WY; Wu H; Wu MC; Shen F; Yang T
    Surgery; 2019 Mar; 165(3):516-524. PubMed ID: 30337048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic Profiling of Combined Hepatocellular Cholangiocarcinoma Reveals Genomics Similar to Either Hepatocellular Carcinoma or Cholangiocarcinoma.
    Murugesan K; Sharaf R; Montesion M; Moore JA; Pao J; Pavlick DC; Frampton GM; Upadhyay VA; Alexander BM; Miller VA; Javle MM; Bekaii Saab TS; Albacker LA; Ross JS; Ali SM
    JCO Precis Oncol; 2021 Aug; 5():. PubMed ID: 34476330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial DNA haplogroup M is associated with late onset of hepatocellular carcinoma.
    Guo Z; Yang H; Wang C; Liu S
    Exp Ther Med; 2012 Mar; 3(3):499-502. PubMed ID: 22969918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic sequencing identifies WNK2 as a driver in hepatocellular carcinoma and a risk factor for early recurrence.
    Zhou SL; Zhou ZJ; Hu ZQ; Song CL; Luo YJ; Luo CB; Xin HY; Yang XR; Shi YH; Wang Z; Huang XW; Cao Y; Fan J; Zhou J
    J Hepatol; 2019 Dec; 71(6):1152-1163. PubMed ID: 31349001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Versus Late Recurrence of Hepatocellular Carcinoma After Surgical Resection Based on Post-recurrence Survival: an International Multi-institutional Analysis.
    Wei T; Zhang XF; Bagante F; Ratti F; Marques HP; Silva S; Soubrane O; Lam V; Poultsides GA; Popescu I; Grigorie R; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Lv Y; Aldrighetti L; Pawlik TM
    J Gastrointest Surg; 2021 Jan; 25(1):125-133. PubMed ID: 32128681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.